BRIEF published on 07/16/2026 at 09:12, 3 months 28 days ago Valerio Therapeutics and Abivax join forces for innovative therapies Abivax Collaboration Inflammatory Diseases Valerio Therapeutics RNA Therapies
PRESS RELEASE published on 07/16/2026 at 09:07, 3 months 28 days ago Inside Information / Other news releases Valerio Therapeutics partners with Abivax for global collaboration, providing pipeline update on RNA therapeutics. Initial payment up to €2.4 million Abivax Collaboration Valerio Therapeutics Pipeline Update RNA Therapeutics
PRESS RELEASE published on 07/16/2026 at 09:07, 3 months 28 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce une collaboration de développement avec Abivax, met à jour son pipeline de thérapies de précision ARN Développement Abivax Collaboration Pipeline Valerio Therapeutics
BRIEF published on 07/01/2026 at 09:27, 4 months 12 days ago Valerio Therapeutics Proposes to Acquire Etherna Immunotherapies Biotechnology Valerio Therapeutics Acquisition Deal RNA Medicines Etherna Immunotherapies
BRIEF published on 07/01/2026 at 09:27, 4 months 12 days ago Valerio Therapeutics is preparing to acquire Etherna Immunotherapies Valerio Therapeutics Biotechnology Investment Etherna Acquisition RNA Drugs Mergers Of Companies
BRIEF published on 07/01/2026 at 09:27, 4 months 12 days ago Valerio Therapeutics propose d'acquérir Etherna Immunotherapies Biotechnologie Accord D'acquisition Valerio Thérapeutique Médicaments À Base D'ARN Immunothérapies Etherna
BRIEF published on 07/01/2026 at 09:27, 4 months 12 days ago Valerio Therapeutics prépare l'acquisition d'Etherna Immunotherapies Valerio Therapeutics Investissement Biotechnologie Acquisition Etherna Médicaments ARN Fusion Entreprises
PRESS RELEASE published on 07/01/2026 at 09:22, 4 months 12 days ago Inside Information / Other news releases Valerio Therapeutics announces binding offer to acquire Etherna Immunotherapies, creating global leader in targeted RNA medicines. Strategic move unlocked by leading investors Acquisition Valerio Therapeutics RNA Medicines Targeted Delivery Etherna Immunotherapies
PRESS RELEASE published on 07/01/2026 at 09:22, 4 months 12 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce l'acquisition d'Etherna Immunotherapies, devenant ainsi un leader mondial des médicaments à base d'ARN ciblés. L'opération vise à combiner deux technologies pour le développement de nouveaux traitements Acquisition Innovation Biotechnologie Valerio Therapeutics Médicaments ARN Ciblés
BRIEF published on 06/16/2026 at 19:48, 4 months 27 days ago Valerio Therapeutics nomme un nouveau PDG et confirme les résolutions de son assemblée générale annuelle Biotechnologie Transition Du PDG Valerio Thérapeutique Gilles Besin Médicaments À Base D'ARN
Published on 11/14/2026 at 01:30, 2 hours 1 minute ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 2 hours 51 minutes ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 2 hours 56 minutes ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 3 hours 31 minutes ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:15, 4 hours 16 minutes ago Core Critical Metals Corp. Announces $500,000 Non-Brokered Critical Mineral Flow-Through Private Placement
Published on 11/13/2026 at 23:24, 4 hours 6 minutes ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 5 hours 38 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 8 hours 22 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 8 hours 31 minutes ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 15 hours 55 minutes ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 15 hours 55 minutes ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 19 hours 31 minutes ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 1 day 4 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
